US/UK/Canada

Share

Quotes

With more than 300,000 deaths over the last eight years, substance abuse has been killing more people than any war.
Dr. Sanjay Gupta, President American Pain Association
Education and compassion are essential to achieving global acceptance of and access to cannabis.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"...may we reflect on how far we have come and continue to work toward the common goal of global cannabis access"
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"The goal of these new advances in cannabis-based medicine – and the reintroduction of cannabis in healthcare – is to leave an indelible mark on the healthcare industry."
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
It is clear that cannabis has reached the tipping point in the minds of the U.S. population.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
“It is clear that cannabis has reached the tipping point in the minds of the U.S. population.”
Dr. Stuart Titus, CEO - Medical Marijuana, Inc.
Pick a time period -
Tags ( Active)

MEDICAL MARIJUNA, INC. INVESTMENT AXIM® BIOTECH RECEIVES POSITIVE PK DATA RESULTS FOR CANCHEW PLUS ® CBD GUM

AXIM Biotechnologies Announces Positive Pharmacokinetic (PK) Data Results on Proprietary Delivery Method for Cannabinoids in Chewing GumMedical Marijuana, Inc.  (OTC: MJNA ), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech)  (OTC: AXIM) has received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical

Article Names Medical Marijuana, Inc. and AXIM ® Biotech as Two of “10 Largest Marijuana Companies Raking in Huge Profits”

Medical Marijuana, Inc.  (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, today announced that the Company was featured in a recent High Times article, “10 Largest Marijuana Companies Raking in Huge Profits .” Using data from well-respected firm Viridian Capital Advisors , a group of Wall Street analysts and bankers focused on cannabis investing who also maintain a cannabis stock index 

Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR

Partnership to Provide Expanded Accessibility to RSHO™, the First-Ever Product Approved for Import by Brazilian GovernmentMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced a groundbreaking partnership between their subsidiary, HempMeds® Brasil  and Paragon HealthCare BR, one of the leading global wholesale distributors of pharmaceutical products. The partnership between HempMeds® Brasil  and Paragon HealthCare BR will

Medical Marijuana, Inc. Featured in L.A. Weekly Profile Story Covering Historic Export Agreements With Mexico, Other Latin American Nations

Article Features Unique Nature of Export Agreement of Cannabis-Related Products From Southern California to Latin AmericaMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its subsidiary HempMeds® Mexico  and its products were featured in an L.A. Weekly  article focused on the first-ever import permit granted by Mexico

Medical Marijuana, Inc.’s Year in Review: 2016 Vote for Cannabis Reform in 8 States, International Expansion Highlight Historic Year

Company Releases Recap Report of Activities in 2016 and Announces Excitement for Coming YearMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced the release of a 2016 business year in review posted to their website HERE . As you can view HERE , Medical Marijuana, Inc., has long been “A Company of First”. 2016 continued to show the company’s progress

Medical Marijuana, Inc. Releases In-Depth Video Series Featuring New Executive Team and Lives Strengthened by Company’s Products

Company Provides Real-Life Testimony Displaying Its Origins, Unprecedented Firsts and Major Accomplishments in 2016Medical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced the release of an in-depth video series showcasing the Company’s history and unprecedented accomplishments as a “Company of Firsts.” From establishing the nation’s first cannabidiol (CBD) oil pipeline from Europe to the U.S. to creating a standard for lab testing of cannabis products, the video series highlights the many

Medical Marijuana, Inc. Subsidiary HempMeds Brasil™ Begins Importation of Real Scientific Hemp Oil-X ™ Product Line Into Brazil

Consumers Looking for Zero THC Version of Real Scientific Hemp Oil (RSHO™) Products Now Have Solution From First-Ever Approved CompanyMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Real Scientific Hemp Oil-X™ (RSHO-X™)  product line is now being imported into Brazil through the company’s subsidiary, HempMeds Brasil™ . The RSHO-X™ 

Medical Marijuana, Inc. Subsidiary HempMeds Brasil™ , Welcomes Caroline Heinz to Executive Team

Ms. Heinz Joins HempMeds Brasil™ Team as New Director of Operations for Brazil-Based CompanyMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that Caroline Heinz has been appointed as the new Director of Operations for their subsidiary, HempMeds Brasil ™. Heinz has played a vital role as part of the HempMeds Brasil 

Medical Marijuana, Inc. Subsidiary HempMeds ® Announces Formation of Business Operations in Chile, Begins Importation Into Argentina

Company Continues International Expansion Initiatives with Company Formation in Chile and Begins Importing Real Scientific Hemp Oil™ to Argentinian MarketMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary company HempMeds®  has formed a new business in Chile. Additionally, as part of the company’s Latin American market expansion initiative, the company has begun importing their flagship product Real Scientific Hemp Oil™ (RSHO™) (

Medical Marijuana Inc Announces Excitement for Recent Mexico Cannabis Regulations Vote

New Ruling Helps Move Mexico Closer to Cannabis Legalization in the CountryMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that it commends the Mexican senate for voting in favor of extending regulations for certain cannabis products. With the new regulations, more people in need of cannabis and cannabidiol (CBD) for medical care will have more access to products, including our RSHO brand of products. Medical Marijuana Inc.  subsidiary

Forbes Features Medical Marijuana, Inc. in Article Citing Company’s Sales Data After Starting CBD Market ‘That Could Grow 700% by 2020’

Article Features Positive Growth Stats for the CBD Market and Information on Medical Marijuana, Inc. Products, Investments and Subsidiary CompaniesMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its products and investments were featured in a Forbes  article focused on the current cannabidiol (CBD) market size and anticipated massive growth. The

Medical Marijuana, Inc.’s HempMeds® to Showcase Award-Winning Hemp Oil Cannabidiol (CBD) and Cannabis Beauty Defined Products at A4M World Congress

HempMeds® to Educate Thousands of Global Healthcare Professionals Attending the World Congress on Anti-Aging Medicine on Rapidly Emerging Hemp Cannabidiol (CBD) IndustryMedical Marijuana, Inc.  (OTC: MJNA) announced today that its subsidiary HempMeds®  is exhibiting at the 24th annual American Academy of Anti-Aging Medicine World Congress (A4M), with the Company’s extensive portfolio of retail-ready cannabis products featured at the Venetian/Palazzo Hotel in Las Vegas from Dec. 9-11. HempMeds® 

MEDICAL MARIJUANA, INC.’s INVESTMENT COMPANY AXIM® BIOTECH RECEIVES APPROVAL FROM MEDICAL ETHICAL COMMITTEE TO BEGIN IBS TRIAL FOR CBD PRODUCT

Company’s Major Investment AXIM Biotech to Begin Study on Patients with IBS with the CanChew Plus® CBD-containing Chewing GumMedical Marijuana, Inc.  (OTC: MJNA ), the world’s leading cannabis portfolio company and first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM) received approval from the Medical Ethical Committee (METC) of Wageningen University in The Netherlands to begin a study

MEDICAL MARIJUANA, INC.’S INVESTMENT AXIM® BIOTECH FILES IP APPLICATION ON PROPIETARY METHOD TO EXTRACT HIGH-PURITY THC

Company’s Major Investment company Announces Filing of Protection for Proprietary Method of THC Extraction that will Achieve Highest THC Purity Level on the MarketMedical Marijuana, Inc.  (OTC: MJNA ), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech ) (OTC: AXIM) has filed an IP application 

MEDICAL MARIJUANA, INC. SUBSIDIARY HEMPMEDS® MEXICO BEGINS DISTRIBUTION OF FLAGSHIP PRODUCT REAL SCIENTIFIC HEMP OIL™ TO COLOMBIAN MARKET

Company’s Subsidiary HempMeds® Mexico Begins Taking Private Orders for RSHO™ in Colombia, Showcases Products at Expo Mede Weed 2016 in City of MedellinMedical Marijuana, Inc.  (OTC: MJNA ) announced today that its subsidiary HempMeds® Mexico , the first and only company with approval from COFEPRIS  to legally import a cannabis product into Mexico, has begun distributing Real Scientific Hemp Oil™ 

NEWSWEEK COVER STORY DOCUMENTS MEDICAL MARIJUANA, INC.’S FIRST-EVER FEDERALLY APPROVED CBD PRODUCT IN MEXICO RSHO-X™

HempMeds® Mexico  Continues Education, Expansion, Advancements in Mexico as Demand Increases for its RSHO-X™ Across CountryMedical Marijuana, Inc.  (OTC PINK: MJNA) announced today that Newsweek featured its subsidiary HempMeds® Mexico ‘s non-psychoactive, THC-free hemp-based cannabidiol (CBD) product Real Scientific Hemp Oil-X™  (RSHO-X™), the first-ever

NBC 7 ‘FOOTBALL NIGHT’ SEGMENT HIGHLIGHTS INTERVIEW WITH MEDICAL MARIJUANA, INC. CEO ABOUT CANNABIS, CONCUSSIONS AND NEW NFLPA PANEL

NBC News Story Quotes Former NFL Player That “There Is a Shift Happening” With the NFL’s Anti-Cannabis Policy, NBC Report Cites New NFLPA CommitteeMedical Marijuana, Inc.  (OTC: MJNA ) is pleased to announce that a new report from NBC 7’s “Football Night”  features an interview with the Company’s CEO Dr. Stuart Titus discussing new research about cannabis and concussions, along with a testimonial from a former NFL player. The NBC News

MEDICAL MARIJUANA, INC.’S KANNAWAY, LLC LAUNCHES REFRESH OF WORLD-RENOWNED BRAND AT ‘GENESIS’ EVENT IN SAN DIEGO

Company Introduced New Leadership and Three New Products at Event, Kannaway Pure CBD Liquid, Kannaway Pure CBD Capsules, and Kannaway Premium Hemp Oil Capsules.Medical Marijuana, Inc.  (OTC: MJNA ) announced today that its portfolio company Kannaway, LLC , the first hemp lifestyle direct selling company to offer cannabidiol (CBD) hemp botanical products, launched a refresh of its world-renowned brand at its ‘Genesis: People, Purpose, Passion’ event in San Diego this

U.S. PATENT ALLOWANCE GRANTED TO MEDICAL MARIJUANA, INC.’S INVESTMENT AXIM® BIOTECH FOR USE OF ALL CANNABINOIDS IN ITS CONTROLLED RELEASE CHEWING GUM

Allows Award-Winning Cannabinoid Release Chewing Gum Products to be Used as Delivery Mechanism for All Cannabinoids, Including THC, CBD, CBG, etc.Medical Marijuana, Inc.  (OTC: MJNA ) announced today that its major investment AXIM® Biotechnologies, Inc. (AXIM® Biotech ) (OTC:AXIM), a world leader in hemp cannabinoid research and development, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial

MEDICAL MARIJUANA, INC. WELL POSITIONED TO CAPITALIZE ON THE RAPIDLY GROWING CANNABIS INDUSTRY – BUSINESS REPORT RELEASE – STONEBRIDGE PARTNERS, LLC

StoneBridge Partners, LLC – a global finance communication and consulting firm, announces the release of an in-depth business analysis of Medical Marijuana, Inc . (OTC: MJNA) presented in a comprehensive report. It is offered for viewing and download here . The report, which outlines the company’s formation and current operations, also offers insight into the perceived opportunities in the explosive-growth market of cannabis. It explores

MEDICAL MARIJUANA, INC. GARNERS NATIONAL NEWS COVERAGE ON FOX, ABC, CW ON HISTORIC NIGHT AS MARIJUANA REFORM PASSES ACROSS U.S.

Medical Marijuana, Inc.  (OTC: MJNA ), the first-ever publicly traded cannabis company in the United States, today announced that it has garnered national news coverage in major local and national TV news outlets across the United States about the sweeping electoral victory for marijuana reform across the nation, including the passage of California’s Proposition 64, which legalized marijuana for recreational use in the state. Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus was

PREMIER LIFESTYLE NETWORKING COMPANY KANNAWAY, LLC ADDS 25-YEAR MULTILEVEL MARKETING EXPERT RANDY SCHROEDER AND HIS PROVEN TRAINING MODULE TO COMPANY

Schroeder to Discuss 25-Year Training Module For First Time at Kannaway’s Genesis 2016 Conference in San Diego on Nov. 11&12Kannaway, LLC , the first hemp lifestyle direct selling company to offer cannabidiol (CBD) hemp botanical products, has added a new multi-level marketing expert to its team, Randy Schroeder, who brings with him a 25-year training module to the Company. Topics include “Why Network Marketing” and “Mastering the Art of the Invitation” among others in this on-going video training series exclusive to Kannaway brand ambassadors. Previously

There are no items matching the current filter
There are no more items matching the current filter
Back to top